# EDGAR Filing Document

**Accession Number:** 0000778108
**File Stem:** 0001752724-23-043130
**Filing Date:** 2023-2
**Character Count:** 55349
**Document Hash:** 3fddcfa93ca13cb4dc7fb0f61a0e1e01
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-043130.hdr.sgml**: 20230227

**ACCESSION NUMBER**: 0001752724-23-043130

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221230

**FILED AS OF DATE**: 20230227

**DATE AS OF CHANGE**: 20230227

**PERIOD START**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DELAWARE GROUP EQUITY FUNDS IV
- **CENTRAL INDEX KEY:** 0000778108
- **IRS NUMBER:** 232369628
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-04413
- **FILM NUMBER:** 23674083

**BUSINESS ADDRESS:**
- **STREET 1:** 100 INDEPENDENCE
- **STREET 2:** 610 MARKET STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19106-2354
- **BUSINESS PHONE:** 18005231918

**MAIL ADDRESS:**
- **STREET 1:** 100 INDEPENDENCE
- **STREET 2:** 610 MARKET STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19106-2354

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELAWARE GROUP EQUITY FUNDS IV INC
- **DATE OF NAME CHANGE:** 19970128

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELAWARE GROUP DELCAP FUND INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELCAP FUND INC
- **DATE OF NAME CHANGE:** 19880929

## Series and Classes Contracts Data

### Delaware Healthcare Fund (Series ID: S000018873)

| Class ID   | Class Name          | Ticker Symbol   |
|:---|:---|:---|
| C000052257 | Class A             | DLHAX           |
| C000052258 | Class C             | DLHCX           |
| C000052259 | Class R             | DLRHX           |
| C000052260 | INSTITUTIONAL CLASS | DLHIX           |

## Nport-Ex

Schedule of investments

Delaware Healthcare Fund December 31, 2022 (Unaudited)

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks — 99.92%♦** | &nbsp;&nbsp;**Common Stocks — 99.92%♦** | &nbsp;&nbsp;**Common Stocks — 99.92%♦** |
| &nbsp;&nbsp;Biotechnology — 31.60% | &nbsp;&nbsp;Biotechnology — 31.60% | &nbsp;&nbsp;Biotechnology — 31.60% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ACADIA Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;160000 | &nbsp;&nbsp;$2547200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alkermes † | &nbsp;&nbsp;&nbsp;&nbsp;423142 | &nbsp;&nbsp;&nbsp;&nbsp; 11056701 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Allogene Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;146779 | &nbsp;&nbsp;&nbsp;&nbsp; 923240 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alnylam Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;41000 | &nbsp;&nbsp;&nbsp;&nbsp; 9743650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Altimmune † | &nbsp;&nbsp;&nbsp;&nbsp;208685 | &nbsp;&nbsp;&nbsp;&nbsp; 3432868 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amarin ADR † | &nbsp;&nbsp;&nbsp;&nbsp;190000 | &nbsp;&nbsp;&nbsp;&nbsp; 229900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AnaptysBio † | &nbsp;&nbsp;&nbsp;&nbsp;93732 | &nbsp;&nbsp;&nbsp;&nbsp; 2904755 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Arcus Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;379100 | &nbsp;&nbsp;&nbsp;&nbsp; 7839788 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Atea Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 336700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Athenex † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 10325 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BioMarin Pharmaceutical † | &nbsp;&nbsp;&nbsp;&nbsp;124000 | &nbsp;&nbsp;&nbsp;&nbsp; 12832760 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BioNTech ADR | &nbsp;&nbsp;&nbsp;&nbsp;18000 | &nbsp;&nbsp;&nbsp;&nbsp; 2703960 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cellectis ADR † | &nbsp;&nbsp;&nbsp;&nbsp;226875 | &nbsp;&nbsp;&nbsp;&nbsp; 476438 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clovis Oncology † | &nbsp;&nbsp;&nbsp;&nbsp;250200 | &nbsp;&nbsp;&nbsp;&nbsp; 13198 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cogent Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;230000 | &nbsp;&nbsp;&nbsp;&nbsp; 2658800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coherus Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;430000 | &nbsp;&nbsp;&nbsp;&nbsp; 3405600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compugen † | &nbsp;&nbsp;&nbsp;&nbsp;852941 | &nbsp;&nbsp;&nbsp;&nbsp; 610450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Day One Biopharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;110000 | &nbsp;&nbsp;&nbsp;&nbsp; 2367200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dynavax Technologies † | &nbsp;&nbsp;&nbsp;&nbsp;760000 | &nbsp;&nbsp;&nbsp;&nbsp; 8086400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exact Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;96353 | &nbsp;&nbsp;&nbsp;&nbsp; 4770437 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fortress Biotech † | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 65500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Galmed Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;306010 | &nbsp;&nbsp;&nbsp;&nbsp; 153005 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incyte † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 6425600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intellia Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;20000 | &nbsp;&nbsp;&nbsp;&nbsp; 697800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intercept Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;27000 | &nbsp;&nbsp;&nbsp;&nbsp; 333990 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Karyopharm Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;380000 | &nbsp;&nbsp;&nbsp;&nbsp; 1292000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landos Biopharma † | &nbsp;&nbsp;&nbsp;&nbsp;147182 | &nbsp;&nbsp;&nbsp;&nbsp; 73606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MacroGenics † | &nbsp;&nbsp;&nbsp;&nbsp;420000 | &nbsp;&nbsp;&nbsp;&nbsp; 2818200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Madrigal Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;28500 | &nbsp;&nbsp;&nbsp;&nbsp; 8272125 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MEI Pharma † | &nbsp;&nbsp;&nbsp;&nbsp;600000 | &nbsp;&nbsp;&nbsp;&nbsp; 146160 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mersana Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;150000 | &nbsp;&nbsp;&nbsp;&nbsp; 879000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mirati Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;60000 | &nbsp;&nbsp;&nbsp;&nbsp; 2718600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moderna † | &nbsp;&nbsp;&nbsp;&nbsp;18000 | &nbsp;&nbsp;&nbsp;&nbsp; 3233160 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MorphoSys † | &nbsp;&nbsp;&nbsp;&nbsp;300000 | &nbsp;&nbsp;&nbsp;&nbsp; 4242193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mustang Bio † | &nbsp;&nbsp;&nbsp;&nbsp;120000 | &nbsp;&nbsp;&nbsp;&nbsp; 47388 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Myriad Genetics † | &nbsp;&nbsp;&nbsp;&nbsp;135000 | &nbsp;&nbsp;&nbsp;&nbsp; 1958850 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nektar Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;256385 | &nbsp;&nbsp;&nbsp;&nbsp; 579430 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neurocrine Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;110000 | &nbsp;&nbsp;&nbsp;&nbsp; 13138400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NextCure † | &nbsp;&nbsp;&nbsp;&nbsp;150000 | &nbsp;&nbsp;&nbsp;&nbsp; 211500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ProQR Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;620000 | &nbsp;&nbsp;&nbsp;&nbsp; 2294000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provention Bio † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 739900 |

---

NQ-G4 [12/22] 2/23 (2741231) 1

------

Schedule of investments

Delaware Healthcare Fund (Unaudited)

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks♦ (continued)** | &nbsp;&nbsp;**Common Stocks♦ (continued)** | &nbsp;&nbsp;**Common Stocks♦ (continued)** |
| &nbsp;&nbsp;Biotechnology (continued) | &nbsp;&nbsp;Biotechnology (continued) | &nbsp;&nbsp;Biotechnology (continued) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Puma Biotechnology † | &nbsp;&nbsp;&nbsp;&nbsp;61255 | &nbsp;&nbsp;$259109 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regeneron Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;90000 | &nbsp;&nbsp;&nbsp;&nbsp; 64934100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REGENXBIO † | &nbsp;&nbsp;&nbsp;&nbsp;149000 | &nbsp;&nbsp;&nbsp;&nbsp; 3379320 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rigel Pharmaceuticals † | 1600000 | &nbsp;&nbsp;&nbsp;&nbsp; 2400000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rocket Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;58000 | &nbsp;&nbsp;&nbsp;&nbsp; 1135060 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roivant Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;338181 | &nbsp;&nbsp;&nbsp;&nbsp; 2702066 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sangamo Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;400000 | &nbsp;&nbsp;&nbsp;&nbsp; 1256000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sarepta Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;13000 | &nbsp;&nbsp;&nbsp;&nbsp; 1684540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seagen † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 10280800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sio Gene Therapies † | &nbsp;&nbsp;&nbsp;&nbsp;64171 | &nbsp;&nbsp;&nbsp;&nbsp; 27914 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Surface Oncology † | &nbsp;&nbsp;&nbsp;&nbsp;350000 | &nbsp;&nbsp;&nbsp;&nbsp; 287000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Syndax Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;180000 | &nbsp;&nbsp;&nbsp;&nbsp; 4581000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tarsus Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;172908 | &nbsp;&nbsp;&nbsp;&nbsp; 2534831 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Theravance Biopharma † | &nbsp;&nbsp;&nbsp;&nbsp;208783 | &nbsp;&nbsp;&nbsp;&nbsp; 2342545 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ultragenyx Pharmaceutical † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 3243100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;uniQure † | &nbsp;&nbsp;&nbsp;&nbsp;706166 | &nbsp;&nbsp;&nbsp;&nbsp; 16008783 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 22247200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;25000 | &nbsp;&nbsp;&nbsp;&nbsp; 7219500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viking Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;330100 | &nbsp;&nbsp;&nbsp;&nbsp; 3102940 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Voyager Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5700 | &nbsp;&nbsp;&nbsp;&nbsp; 34770 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WaVe Life Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;81955 | &nbsp;&nbsp;&nbsp;&nbsp; 573685 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Xencor † | &nbsp;&nbsp;&nbsp;&nbsp;129191 | &nbsp;&nbsp;&nbsp;&nbsp; 3364134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;XOMA † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3466 | &nbsp;&nbsp;&nbsp;&nbsp; 63774 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yumanity Therapeutics = | &nbsp;&nbsp;&nbsp;&nbsp;750000 | &nbsp;&nbsp;&nbsp;&nbsp; 0 |
|  |  | &nbsp;&nbsp;&nbsp;280932948 |
| &nbsp;&nbsp;Blue Chip Medical Products — 43.91% | &nbsp;&nbsp;Blue Chip Medical Products — 43.91% | &nbsp;&nbsp;Blue Chip Medical Products — 43.91% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AbbVie | &nbsp;&nbsp;&nbsp;&nbsp;226559 | &nbsp;&nbsp;&nbsp;&nbsp; 36614200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amgen | &nbsp;&nbsp;&nbsp;&nbsp;246964 | &nbsp;&nbsp;&nbsp;&nbsp; 64862625 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca | &nbsp;&nbsp;&nbsp;&nbsp;131243 | &nbsp;&nbsp;&nbsp;&nbsp; 17799177 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biogen † | &nbsp;&nbsp;&nbsp;&nbsp;45000 | &nbsp;&nbsp;&nbsp;&nbsp; 12461400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Boston Scientific † | &nbsp;&nbsp;&nbsp;&nbsp;380000 | &nbsp;&nbsp;&nbsp;&nbsp; 17582600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chugai Pharmaceutical | &nbsp;&nbsp;&nbsp;&nbsp;700000 | &nbsp;&nbsp;&nbsp;&nbsp; 17964035 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eli Lilly & Co. | &nbsp;&nbsp;&nbsp;&nbsp;130000 | &nbsp;&nbsp;&nbsp;&nbsp; 47559200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Euroapi † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8695 | &nbsp;&nbsp;&nbsp;&nbsp; 128910 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gilead Sciences | &nbsp;&nbsp;&nbsp;&nbsp;195000 | &nbsp;&nbsp;&nbsp;&nbsp; 16740750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Haleon † | &nbsp;&nbsp;&nbsp;&nbsp;313421 | &nbsp;&nbsp;&nbsp;&nbsp; 1240363 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Johnson & Johnson | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 17665000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merck & Co. | &nbsp;&nbsp;&nbsp;&nbsp;295000 | &nbsp;&nbsp;&nbsp;&nbsp; 32730250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Organon & Co. | &nbsp;&nbsp;&nbsp;&nbsp;29500 | &nbsp;&nbsp;&nbsp;&nbsp; 823935 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pfizer | &nbsp;&nbsp;&nbsp;&nbsp;604600 | &nbsp;&nbsp;&nbsp;&nbsp; 30979704 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roche Holding | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 25133834 |

---

2 NQ-G4 [12/22] 2/23 (2741231)

------

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks♦ (continued)** | &nbsp;&nbsp;**Common Stocks♦ (continued)** | &nbsp;&nbsp;**Common Stocks♦ (continued)** |
| &nbsp;&nbsp;Blue Chip Medical Products (continued) | &nbsp;&nbsp;Blue Chip Medical Products (continued) | &nbsp;&nbsp;Blue Chip Medical Products (continued) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sanofi | &nbsp;&nbsp;&nbsp;&nbsp;200000 | &nbsp;&nbsp;$19233846 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sanofi ADR | &nbsp;&nbsp;&nbsp;&nbsp;225000 | &nbsp;&nbsp;&nbsp;&nbsp; 10896750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stryker | &nbsp;&nbsp;&nbsp;&nbsp;15000 | &nbsp;&nbsp;&nbsp;&nbsp; 3667350 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UCB | &nbsp;&nbsp;&nbsp;&nbsp;76000 | &nbsp;&nbsp;&nbsp;&nbsp; 5984415 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zimmer Biomet Holdings | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 10200000 |
|  |  | &nbsp;&nbsp;&nbsp;390268344 |
| &nbsp;&nbsp;Healthcare Services — 14.10% | &nbsp;&nbsp;Healthcare Services — 14.10% | &nbsp;&nbsp;Healthcare Services — 14.10% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CVS Health | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 9319000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elevance Health | &nbsp;&nbsp;&nbsp;&nbsp;87500 | &nbsp;&nbsp;&nbsp;&nbsp; 44884875 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quest Diagnostics | &nbsp;&nbsp;&nbsp;&nbsp;48000 | &nbsp;&nbsp;&nbsp;&nbsp; 7509120 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group | &nbsp;&nbsp;&nbsp;&nbsp;120000 | &nbsp;&nbsp;&nbsp;&nbsp; 63621600 |
|  |  | &nbsp;&nbsp;&nbsp;125334595 |
| &nbsp;&nbsp;Other — 0.75% | &nbsp;&nbsp;Other — 0.75% | &nbsp;&nbsp;Other — 0.75% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cia de Minas Buenaventura ADR | &nbsp;&nbsp;&nbsp;&nbsp;66353 | &nbsp;&nbsp;&nbsp;&nbsp; 494330 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae † | 1300000 | &nbsp;&nbsp;&nbsp;&nbsp; 459420 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Federal Home Loan Mortgage † | 1050000 | &nbsp;&nbsp;&nbsp;&nbsp; 370965 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sohu.com ADR † | &nbsp;&nbsp;&nbsp;&nbsp;390722 | &nbsp;&nbsp;&nbsp;&nbsp; 5356798 |
|  |  | &nbsp;&nbsp;&nbsp; 6681513 |
| &nbsp;&nbsp;Small- / Mid-Cap Medical Products — 9.56% | &nbsp;&nbsp;Small- / Mid-Cap Medical Products — 9.56% | &nbsp;&nbsp;Small- / Mid-Cap Medical Products — 9.56% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Halozyme Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;230000 | &nbsp;&nbsp;&nbsp;&nbsp; 13087000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Illumina † | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 20220000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;InnoCare Pharma 144A #, † | &nbsp;&nbsp;&nbsp;&nbsp;17000 | &nbsp;&nbsp;&nbsp;&nbsp; 29708 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inspire Medical Systems † | &nbsp;&nbsp;&nbsp;&nbsp;30000 | &nbsp;&nbsp;&nbsp;&nbsp; 7556400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intra-Cellular Therapies † | &nbsp;&nbsp;&nbsp;&nbsp;450000 | &nbsp;&nbsp;&nbsp;&nbsp; 23814000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Perrigo | &nbsp;&nbsp;&nbsp;&nbsp;210000 | &nbsp;&nbsp;&nbsp;&nbsp; 7158900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viatris | 1170018 | &nbsp;&nbsp;&nbsp;&nbsp; 13022300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zimvie † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8000 | &nbsp;&nbsp;&nbsp;&nbsp; 74720 |
|  |  | &nbsp;&nbsp;&nbsp; 84963028 |
| &nbsp;&nbsp;&nbsp;**Total Common Stocks (cost $648,637,680)** | &nbsp;&nbsp;&nbsp;**Total Common Stocks (cost $648,637,680)** | &nbsp;&nbsp;&nbsp;**888180428** |

---

NQ-G4 [12/22] 2/23 (2741231) 3

------

Schedule of investments

Delaware Healthcare Fund (Unaudited)

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Rights — 0.00%** | &nbsp;&nbsp;**Rights — 0.00%** | &nbsp;&nbsp;**Rights — 0.00%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ambit Bioscience = | &nbsp;&nbsp;&nbsp;&nbsp;76500 | &nbsp;&nbsp;$0 |
| &nbsp;&nbsp;&nbsp;**Total Rights (cost $0)** | &nbsp;&nbsp;&nbsp;**Total Rights (cost $0)** | &nbsp;&nbsp;&nbsp; **0** |
| &nbsp;&nbsp;&nbsp;**Total Value of Securities—99.92%<br> (cost $648,637,680)** |  | &nbsp;&nbsp;&nbsp;&nbsp;**888180428** |
| &nbsp;&nbsp;&nbsp;**Receivables and Other Assets Net of Liabilities—0.08%** |  | &nbsp;&nbsp;&nbsp;&nbsp; **690849** |
| &nbsp;&nbsp;&nbsp;**Net Assets Applicable to 35,277,375 Shares Outstanding—100.00%** |  | &nbsp;&nbsp;**$888871277** |

---

---

| | |
|:---|:---|
| ♦ | Narrow industries are utilized for compliance purposes for concentration whereas broad sectors are used for financial reporting. |
| <sup>†</sup> | Non-income producing security. |
| <sup>=</sup> | The value of this security was determined using significant unobservable inputs and is reported as a Level 3 security. |
| <sup>#</sup> | Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. At December 31, 2022, the aggregate value of Rule 144A securities was $29,708, which represents 0.00% of the Fund's net assets. |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Foreign Currency Exchange Contracts** | **Foreign Currency Exchange Contracts** | **Foreign Currency Exchange Contracts** | **Foreign Currency Exchange Contracts** | **Foreign Currency Exchange Contracts** |  |  |
| Counterparty | &nbsp;&nbsp;&nbsp;Currency to<br> Receive (Deliver) | &nbsp;&nbsp;&nbsp;Currency to<br> Receive (Deliver) | &nbsp;&nbsp;&nbsp;In Exchange For | &nbsp;&nbsp;&nbsp;In Exchange For | &nbsp;&nbsp;&nbsp;Settlement<br> Date | &nbsp;&nbsp;&nbsp;Unrealized<br> Depreciation |
| BNYM | &nbsp;&nbsp;GBP | &nbsp;&nbsp;(3612296) | &nbsp;&nbsp;USD | &nbsp;&nbsp;4356417 | &nbsp;&nbsp;1/3/23 | &nbsp;&nbsp;&nbsp;$(11131) |

---

The use of foreign currency exchange contracts involves elements of market risk and risks in excess of the amounts disclosed in the financial statements. The foreign currency exchange contract presented above represent the Fund's total exposure in such contracts, whereas only the net unrealized appreciation (depreciation) is reflected in the Fund's net assets.

---

| |
|:---|
| **Summary of abbreviations:** |
| ADR – American Depositary Receipt |
| BNYM – Bank of New York Mellon |

---

---

| |
|:---|
| **Summary of currencies:** |
| GBP – British Pound Sterling |
| USD – US Dollar |

---

4 NQ-G4 [12/22] 2/23 (2741231)

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Delaware Group Equity Funds IV

- **b. Investment Company Act file number:** 811-04413

- **c. CIK number of Registrant:** 0000778108

- **d. LEI of Registrant:** 549300OT9UDUW3MXT836

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 100 Independence

  - **City:** Philadelphia

  - **State:** PA

  - **Foreign country:** US

  - **Zip / Postal Code:** 19106-2354

  - **Telephone number:** 800-523-1918

**Item A.2. Information about the Series.**

- **a. Name of Series:** Delaware Healthcare Fund

- **b. EDGAR series identifier (if any):** S000018873

- **c. LEI of Series:** 3T01W8DZEUUPS0D3VS95

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-03-31

- **b. Date as of which information is reported:** 2022-12-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $897039576.56

**Total Liabilities:** $7569647.19

**Net Assets:** $889469929.37

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000052257 | 8.73%                | 5.58%                | -1.88%               |
| Class ID C000052258 | 8.65%                | 5.50%                | -1.94%               |
| Class ID C000052259 | 8.71%                | 5.58%                | -1.93%               |
| Class ID C000052260 | 8.76%                | 5.59%                | -1.86%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-1236828.23             | $72355350.66                               |
| Month 2  | $-197839.89              | $48402140.49                               |
| Month 3  | $-952258.11              | $-16170514.12                              |

### Schedule of Portfolio Investments

| Name                           | Title                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Xencor Inc                     | Xencor Inc                            | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |    129191 | NS      | $3364133.64   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                    | Incyte Corp                           | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     80000 | NS      | $6425600.00   | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi                         | Sanofi                                | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    200000 | NS      | $19233845.60  | 2.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc     | Neurocrine Biosciences Inc            | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |    110000 | NS      | $13138400.00  | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Cia de Minas Buenaventura SAA  | Cia de Minas Buenaventura SAA         | CUSIP: 204448104<br>LEI: 529900WQB1ZU9KB6EL71 | Long             | EC               | CORP              | PE        |     66353 | NS      | $494329.85    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| MacroGenics Inc                | MacroGenics Inc                       | CUSIP: 556099109<br>LEI: 5493001KJQUA83L8MH79 | Long             | EC               | CORP              | US        |    420000 | NS      | $2818200.00   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Fannie Mae                     | Federal National Mortgage Association | CUSIP: 313586109<br>LEI: B1V7KEBTPIMZEU4LTD58 | Long             | EC               | USGSE             | US        |   1300000 | NS      | $459420.00    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                      | Amgen Inc                             | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |    246964 | NS      | $64862624.96  | 7.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc      | Halozyme Therapeutics Inc             | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |    230000 | NS      | $13087000.00  | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Sio Gene Therapies Inc         | Sio Gene Therapies Inc                | CUSIP: 829399104<br>LEI: 529900F0GBLJ6D003G43 | Long             | EC               | CORP              | US        |     64171 | NS      | $27914.39     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp         | Boston Scientific Corp                | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    380000 | NS      | $17582600.00  | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                         | UCB SA                                | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |     76000 | NS      | $5984414.95   | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| ProQR Therapeutics NV          | ProQR Therapeutics NV                 | CUSIP: 000000000<br>LEI: 549300NGS2FJGGDBGS06 | Long             | EC               | CORP              | NL        |    620000 | NS      | $2294000.00   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| XOMA Corp                      | XOMA Corp                             | CUSIP: 98419J206<br>LEI: 549300U6ZVYFCWNBJ613 | Long             | EC               | CORP              | US        |      3466 | NS      | $63774.40     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Quest Diagnostics Inc          | Quest Diagnostics Inc                 | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     48000 | NS      | $7509120.00   | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi                         | Sanofi                                | CUSIP: 80105N105<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    225000 | NS      | $10896750.00  | 1.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc      | Intellia Therapeutics Inc             | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     20000 | NS      | $697800.00    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd   | Chugai Pharmaceutical Co Ltd          | CUSIP: 000000000<br>LEI: 529900T9LAII161DCN95 | Long             | EC               | CORP              | JP        |    700000 | NS      | $17964035.36  | 2.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Haleon PLC                     | Haleon PLC                            | CUSIP: 000000000<br>LEI: 549300PSB3WWEODCUP19 | Long             | EC               | CORP              | GB        |    313421 | NS      | $1240362.93   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc   | Madrigal Pharmaceuticals Inc          | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |     28500 | NS      | $8272125.00   | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Compugen Ltd                   | Compugen Ltd                          | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IL        |    852941 | NS      | $610449.87    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG               | Roche Holding AG                      | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     80000 | NS      | $25133834.42  | 2.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp            | Exact Sciences Corp                   | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |     96353 | NS      | $4770437.03   | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Athenex Inc                    | Athenex Inc                           | CUSIP: 04685N103<br>LEI: 5493001V4L0Q5EPPOH52 | Long             | EC               | CORP              | US        |     70000 | NS      | $10325.00     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc     | Syndax Pharmaceuticals Inc            | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |    180000 | NS      | $4581000.00   | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Galmed Pharmaceuticals Ltd     | Galmed Pharmaceuticals Ltd            | CUSIP: 000000000<br>LEI: 549300FL07PJ8ICSMD04 | Long             | EC               | CORP              | IL        |    306010 | NS      | $153005.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                   | Illumina Inc                          | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    100000 | NS      | $20220000.00  | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                 | Eli Lilly & Co                        | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    130000 | NS      | $47559200.00  | 5.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Mersana Therapeutics Inc       | Mersana Therapeutics Inc              | CUSIP: 59045L106<br>LEI: 529900VWD5VDZ7PVOS22 | Long             | EC               | CORP              | US        |    150000 | NS      | $879000.00    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd           | Roivant Sciences Ltd                  | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | US        |    338181 | NS      | $2702066.19   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| The Bank of New York Mellon    | GBP/USD FORWARD                       | CUSIP: 000000000<br>LEI: HPFHU0OQ28E4N0NFVK49 | N/A              | DFE              | CORP              | US        |         1 | NC      | $-11130.53    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| BioNTech SE                    | BioNTech SE                           | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |     20000 | NS      | $3004400.00   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| MEI Pharma Inc                 | MEI Pharma Inc                        | CUSIP: 55279B202<br>LEI: 529900A43X33ON524197 | Long             | EC               | CORP              | US        |    600000 | NS      | $146160.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Euroapi SA                     | Euroapi SA                            | CUSIP: 000000000<br>LEI: 9695002FT7GGI3CKKJ14 | Long             | EC               | CORP              | FR        |      8695 | NS      | $128909.74    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Myriad Genetics Inc            | Myriad Genetics Inc                   | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |    135000 | NS      | $1958850.00   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                | CVS Health Corp                       | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    100000 | NS      | $9319000.00   | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                   | Stryker Corp                          | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     15000 | NS      | $3667350.00   | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                     | uniQure NV                            | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |    706166 | NS      | $16008783.22  | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals Inc     | ACADIA Pharmaceuticals Inc            | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |    160000 | NS      | $2547200.00   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                    | Moderna Inc                           | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |     26000 | NS      | $4670120.00   | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                | AstraZeneca PLC                       | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    131243 | NS      | $17799177.10  | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc            | Elevance Health Inc                   | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |     87500 | NS      | $44884875.00  | 5.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Provention Bio Inc             | Provention Bio Inc                    | CUSIP: 74374N102<br>LEI: 5493003LM26XAVJKLD34 | Long             | EC               | CORP              | US        |     70000 | NS      | $739900.00    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Surface Oncology Inc           | Surface Oncology Inc                  | CUSIP: 86877M209<br>LEI: 549300FCSG6MNIMFH738 | Long             | EC               | CORP              | US        |    350000 | NS      | $287000.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc      | Allogene Therapeutics Inc             | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    146779 | NS      | $923239.91    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Puma Biotechnology Inc         | Puma Biotechnology Inc                | CUSIP: 74587V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     61255 | NS      | $259108.65    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc  | Regeneron Pharmaceuticals Inc         | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     90000 | NS      | $64934100.00  | 7.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Mustang Bio Inc                | Mustang Bio Inc                       | CUSIP: 62818Q104<br>LEI: 5493004W0VC1DPECQ779 | Long             | EC               | CORP              | US        |    120000 | NS      | $47388.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Clovis Oncology Inc            | Clovis Oncology Inc                   | CUSIP: 189464100<br>LEI: 529900WCUY9ZAHMRV489 | Long             | EC               | CORP              | US        |    250200 | NS      | $13198.05     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc            | Gilead Sciences Inc                   | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    195000 | NS      | $16740750.00  | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Cellectis SA                   | Cellectis SA                          | CUSIP: 15117K103<br>LEI: 5493000KKX5VQ37Q2W83 | Long             | EC               | CORP              | FR        |    226875 | NS      | $476437.50    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson              | Johnson & Johnson                     | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    100000 | NS      | $17665000.00  | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimvie Inc                     | Zimvie Inc                            | CUSIP: 98888T107<br>LEI: 549300GFKURT1J6XR665 | Long             | EC               | CORP              | US        |      8000 | NS      | $74720.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Voyager Therapeutics Inc       | Voyager Therapeutics Inc              | CUSIP: 92915B106<br>LEI: 54930082S4XVR0ZWCC74 | Long             | EC               | CORP              | US        |      5700 | NS      | $34770.00     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| MorphoSys AG                   | MorphoSys AG                          | CUSIP: 000000000<br>LEI: 529900493806K77LRE72 | Long             | EC               | CORP              | DE        |    300000 | NS      | $4242193.35   | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Altimmune Inc                  | Altimmune Inc                         | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |    208685 | NS      | $3432868.25   | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENXBIO Inc                  | REGENXBIO Inc                         | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |    149000 | NS      | $3379320.00   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Landos Biopharma Inc           | Landos Biopharma Inc                  | CUSIP: 515069102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    147182 | NS      | $73605.72     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc    | BioMarin Pharmaceutical Inc           | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |    124000 | NS      | $12832760.00  | 1.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc       | Sarepta Therapeutics Inc              | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |     13000 | NS      | $1684540.00   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics            | Nektar Therapeutics                   | CUSIP: 640268108<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |    256385 | NS      | $579430.10    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Seagen Inc                     | Seagen Inc                            | CUSIP: 81181C104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     80000 | NS      | $10280800.00  | 1.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc     | Tarsus Pharmaceuticals Inc            | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    172908 | NS      | $2534831.28   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc    | Alnylam Pharmaceuticals Inc           | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     41000 | NS      | $9743650.00   | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Fortress Biotech Inc           | Fortress Biotech Inc                  | CUSIP: 34960Q109<br>LEI: 529900DZUWSYUURECK24 | Long             | EC               | CORP              | US        |    100000 | NS      | $65500.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Intra-Cellular Therapies Inc   | Intra-Cellular Therapies Inc          | CUSIP: 46116X101<br>LEI: 5299002U2KGF193IJA20 | Long             | EC               | CORP              | US        |    450000 | NS      | $23814000.00  | 2.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                    | Viatris Inc                           | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |   1170018 | NS      | $13022300.34  | 1.46%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp       | United Therapeutics Corp              | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     80000 | NS      | $22247200.00  | 2.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                   | Alkermes PLC                          | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |    423142 | NS      | $11056700.46  | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Atea Pharmaceuticals Inc       | Atea Pharmaceuticals Inc              | CUSIP: 04683R106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     70000 | NS      | $336700.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc     | Vertex Pharmaceuticals Inc            | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     25000 | NS      | $7219500.00   | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc         | UnitedHealth Group Inc                | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    120000 | NS      | $63621600.00  | 7.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Rocket Pharmaceuticals Inc     | Rocket Pharmaceuticals Inc            | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |     58000 | NS      | $1135060.00   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Proteostasis Theapeutics       | Proteostasis Theapeutics              | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    750000 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Biogen Inc                     | Biogen Inc                            | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     45000 | NS      | $12461400.00  | 1.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                 | Merck & Co Inc                        | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    295000 | NS      | $32730250.00  | 3.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc          | Arcus Biosciences Inc                 | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    379100 | NS      | $7839788.00   | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Sangamo Therapeutics Inc       | Sangamo Therapeutics Inc              | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               | CORP              | US        |    400000 | NS      | $1256000.00   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Day One Biopharmaceuticals Inc | Day One Biopharmaceuticals Inc        | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    110000 | NS      | $2367200.00   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Inspire Medical Systems Inc    | Inspire Medical Systems Inc           | CUSIP: 457730109<br>LEI: 549300XQQCQ7HCJKTW25 | Long             | EC               | CORP              | US        |     30000 | NS      | $7556400.00   | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| NextCure Inc                   | NextCure Inc                          | CUSIP: 65343E108<br>LEI: 549300Y5PR6RJR1STI24 | Long             | EC               | CORP              | US        |    150000 | NS      | $211500.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc  | Ultragenyx Pharmaceutical Inc         | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     70000 | NS      | $3243100.00   | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Freddie Mac                    | Federal Home Loan Mortgage Corp       | CUSIP: 313400301<br>LEI: S6XOOCT0IEG5ABCC6L87 | Long             | EC               | USGSE             | US        |   1050000 | NS      | $370965.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                     | Pfizer Inc                            | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    604600 | NS      | $30979704.00  | 3.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc        | Viking Therapeutics Inc               | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |    330100 | NS      | $3102940.00   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Rigel Pharmaceuticals Inc      | Rigel Pharmaceuticals Inc             | CUSIP: 766559603<br>LEI: 529900KPTNUS5J8K9K66 | Long             | EC               | CORP              | US        |   1600000 | NS      | $2400000.00   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                   | Organon & Co                          | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |     29500 | NS      | $823935.00    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| AMBIT BIOSCIENCES CORP         | AMBIT BIOSCIENCES CORP CVR            | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     76500 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Cogent Biosciences Inc         | Cogent Biosciences Inc                | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    230000 | NS      | $2658800.00   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc     | Zimmer Biomet Holdings Inc            | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |     80000 | NS      | $10200000.00  | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                 | AnaptysBio Inc                        | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |     93732 | NS      | $2904754.68   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                 | Perrigo Co PLC                        | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    210000 | NS      | $7158900.00   | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Intercept Pharmaceuticals Inc  | Intercept Pharmaceuticals Inc         | CUSIP: 45845P108<br>LEI: 254900JMB8TX5P688V24 | Long             | EC               | CORP              | US        |     27000 | NS      | $333990.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd         | WaVe Life Sciences Ltd                | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | US        |     81955 | NS      | $573685.00    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma Inc       | Theravance Biopharma Inc              | CUSIP: 000000000<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |    208783 | NS      | $2342545.26   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                     | AbbVie Inc                            | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    226559 | NS      | $36614199.99  | 4.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Dynavax Technologies Corp      | Dynavax Technologies Corp             | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |    760000 | NS      | $8086400.00   | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Amarin Corp PLC                | Amarin Corp PLC                       | CUSIP: 023111206<br>LEI: 5493009JFIGUFEVPK217 | Long             | EC               | CORP              | IE        |    190000 | NS      | $229900.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Sohu.com Ltd                   | Sohu.com Ltd                          | CUSIP: 83410S108<br>LEI: N/A                  | Long             | EC               | CORP              | CN        |    390722 | NS      | $5356798.62   | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| InnoCare Pharma Ltd            | InnoCare Pharma Ltd                   | CUSIP: 000000000<br>LEI: 3003001NYJPPWIEOJT79 | Long             | EC               | CORP              | CN        |     17000 | NS      | $29707.45     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Coherus Biosciences Inc        | Coherus Biosciences Inc               | CUSIP: 19249H103<br>LEI: 5493007IL8W5MV932D26 | Long             | EC               | CORP              | US        |    430000 | NS      | $3405600.00   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirati Therapeutics Inc        | Mirati Therapeutics Inc               | CUSIP: 60468T105<br>LEI: 529900GYRW59IDQV6N54 | Long             | EC               | CORP              | US        |     60000 | NS      | $2718600.00   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Karyopharm Therapeutics Inc    | Karyopharm Therapeutics Inc           | CUSIP: 48576U106<br>LEI: 549300J1VANRCNTYST87 | Long             | EC               | CORP              | US        |    380000 | NS      | $1292000.00   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-02-22

**Name of Applicant:** Delaware Group Equity Funds IV

**Signature:** Dan Geatens

**Name of Signer:** Dan Geatens

**Title:** Division Director - Head of US Fund Administration